As of 2024-12-15, the Intrinsic Value of Viracta Therapeutics Inc (VIRX) is
-5.45 USD. This VIRX valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.20 USD, the upside of Viracta Therapeutics Inc is
-2,787.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-5.45 USD
Intrinsic Value
VIRX Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-5.45 - -5.45 |
-5.45 |
-2,787.00% |
| P/E |
(20.48) - (20.87) |
(19.77) |
-9853.8% |
| DDM - Stable |
(6.47) - (18.76) |
(12.61) |
-6322.4% |
| DDM - Multi |
(2.08) - (4.78) |
(2.91) |
-1534.4% |
VIRX Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
8.06 |
| Beta |
-0.33 |
| Outstanding shares (mil) |
39.74 |
| Enterprise Value (mil) |
11.84 |
| Market risk premium |
4.60% |
| Cost of Equity |
12.51% |
| Cost of Debt |
5.00% |
| WACC |
5.81% |